Latest price guide for 2025 Apremilast tablets
Apremilast has gradually entered clinical routine treatment in recent years, and its main application areas focus on immune-related diseases such as psoriatic arthritis (PSA) and plaque psoriasis. It reduces the levels of inflammatory mediators throughPDE4 inhibition, helping patients relieve joint inflammation and skin damage. Compared with traditional drugs, it does not require injection and is more convenient to use. Therefore, it has obvious advantages in young patients and long-term maintenance treatment. In overseas guidelines, apremilast has been listed as a second-line or alternative treatment option for a variety of chronic immune diseases. Especially in patients with poor efficacy or poor tolerance to methotrexate or other conventional DMARDs, apremilast provides new treatment opportunities.

In terms of price, currently in the Chinese market, Apremilast has been launched and entered the medical insurance catalog, significantly reducing the financial burden on patients. Most hospital pharmacies can purchase them directly, and the actual costs paid by patients are relatively controllable after being reimbursed by medical insurance. Compared with before it was included in medical insurance, patient accessibility has been significantly improved, which has also promoted the widespread use of this drug in clinical practice. In overseas markets, the price of Apremilast's original drug is still relatively high. For example, the price of the European version is often around more than 10,000 yuan. For patients without medical insurance coverage, the burden of long-term medication is heavy. Therefore, some developing countries have launched generic versions of drugs, such as the generic version of Apremilast in India, Laos and other places. The price is often only a few hundred yuan, which greatly reduces the cost for patients. Therefore, it has become a popular choice for many cross-border drug purchase channels.
It needs to be emphasized that although generic drugs have more advantages in terms of price, the quality and formality of the source of the drug are crucial. If patients consider overseas generic drugs, they should purchase them through formal channels to avoid risks caused by substandard drug sources.
Reference materials:https://go.drugbank.com/drugs/DB05676
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)